COVIVIO (COV.PA) Stock Fundamental Analysis
EPA:COV - Euronext Paris - Matif - FR0000064578 - REIT - Currency: EUR
Overall COV gets a fundamental rating of 3 out of 10. We evaluated COV against 40 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
COV had positive earnings in the past year.
COV had a positive operating cash flow in the past year.
COV had positive earnings in 4 of the past 5 years.
Each year in the past 5 years COV had a positive operating cash flow.
1.2 Ratios
COV has a worse Return On Assets (0.27%) than 67.50% of its industry peers.
The Return On Equity of COV (0.83%) is worse than 67.50% of its industry peers.
COV has a Return On Invested Capital of 3.14%. This is comparable to the rest of the industry: COV outperforms 42.50% of its industry peers.
COV had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 3.63%.
The 3 year average ROIC (2.97%) for COV is below the current ROIC(3.14%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.27% | ||
| ROE | 0.83% | ||
| ROIC | 3.14% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
1.3 Margins
COV has a worse Profit Margin (5.23%) than 65.00% of its industry peers.
In the last couple of years the Profit Margin of COV has declined.
Looking at the Operating Margin, with a value of 61.20%, COV is doing worse than 67.50% of the companies in the same industry.
COV's Operating Margin has been stable in the last couple of years.
COV has a Gross Margin of 76.74%. This is comparable to the rest of the industry: COV outperforms 57.50% of its industry peers.
In the last couple of years the Gross Margin of COV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 61.2% | ||
| PM (TTM) | 5.23% | ||
| GM | 76.74% |
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
2. Health
2.1 Basic Checks
COV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, COV has more shares outstanding
Compared to 5 years ago, COV has more shares outstanding
COV has a better debt/assets ratio than last year.
2.2 Solvency
COV has an Altman-Z score of 0.56. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.56, COV is doing worse than 75.00% of the companies in the same industry.
The Debt to FCF ratio of COV is 27.72, which is on the high side as it means it would take COV, 27.72 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COV (27.72) is worse than 72.50% of its industry peers.
COV has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.14, COV is doing worse than 82.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 27.72 | ||
| Altman-Z | 0.56 |
ROIC/WACC0.55
WACC5.67%
2.3 Liquidity
A Current Ratio of 0.96 indicates that COV may have some problems paying its short term obligations.
COV has a Current ratio of 0.96. This is in the better half of the industry: COV outperforms 67.50% of its industry peers.
A Quick Ratio of 0.85 indicates that COV may have some problems paying its short term obligations.
COV has a better Quick ratio (0.85) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
COV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
The Earnings Per Share has been decreasing by -3.39% on average over the past years.
Looking at the last year, COV shows a very strong growth in Revenue. The Revenue has grown by 22.79%.
COV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.17% yearly.
EPS 1Y (TTM)0%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%5.69%
Revenue 1Y (TTM)22.79%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.62%
3.2 Future
Based on estimates for the next years, COV will show a small growth in Earnings Per Share. The EPS will grow by 1.89% on average per year.
Based on estimates for the next years, COV will show a small growth in Revenue. The Revenue will grow by 4.79% on average per year.
EPS Next Y7.5%
EPS Next 2Y1.92%
EPS Next 3Y1.89%
EPS Next 5YN/A
Revenue Next Year-0.42%
Revenue Next 2Y1.71%
Revenue Next 3Y4.79%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
COV is valuated correctly with a Price/Earnings ratio of 12.01.
Based on the Price/Earnings ratio, COV is valued a bit cheaper than 77.50% of the companies in the same industry.
COV is valuated cheaply when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.17, which indicates a very decent valuation of COV.
The rest of the industry has a similar Price/Forward Earnings ratio as COV.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, COV is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.01 | ||
| Fwd PE | 11.17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COV is on the same level as its industry peers.
COV's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.58 | ||
| EV/EBITDA | 17.41 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.6
PEG (5Y)N/A
EPS Next 2Y1.92%
EPS Next 3Y1.89%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.74%, COV is a good candidate for dividend investing.
COV's Dividend Yield is rather good when compared to the industry average which is at 5.53. COV pays more dividend than 82.50% of the companies in the same industry.
COV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.74% |
5.2 History
The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
COV pays out 112.19% of its income as dividend. This is not a sustainable payout ratio.
DP112.19%
EPS Next 2Y1.92%
EPS Next 3Y1.89%
EPA:COV (6/30/2025, 4:35:46 PM)
53.675
+1.32 (+2.53%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners39.95%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap5.99B
Analysts80
Price Target60.13 (12.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.74% |
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP112.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.08%
PT rev (3m)-4.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.01 | ||
| Fwd PE | 11.17 | ||
| P/S | 4.6 | ||
| P/FCF | 15.58 | ||
| P/OCF | 6.11 | ||
| P/B | 0.73 | ||
| P/tB | 0.76 | ||
| EV/EBITDA | 17.41 |
EPS(TTM)4.47
EY8.33%
EPS(NY)4.81
Fwd EY8.95%
FCF(TTM)3.45
FCFY6.42%
OCF(TTM)8.78
OCFY16.36%
SpS11.66
BVpS73.72
TBVpS70.63
PEG (NY)1.6
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.27% | ||
| ROE | 0.83% | ||
| ROCE | 3.52% | ||
| ROIC | 3.14% | ||
| ROICexc | 3.24% | ||
| ROICexgc | 3.29% | ||
| OM | 61.2% | ||
| PM (TTM) | 5.23% | ||
| GM | 76.74% | ||
| FCFM | 29.56% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexcg growth 3Y12.16%
ROICexcg growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 27.72 | ||
| Debt/EBITDA | 10.32 | ||
| Cap/Depr | 519.44% | ||
| Cap/Sales | 45.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.61% | ||
| Profit Quality | 564.76% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 0.56 |
F-Score7
WACC5.67%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%5.69%
EPS Next Y7.5%
EPS Next 2Y1.92%
EPS Next 3Y1.89%
EPS Next 5YN/A
Revenue 1Y (TTM)22.79%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.62%
Revenue Next Year-0.42%
Revenue Next 2Y1.71%
Revenue Next 3Y4.79%
Revenue Next 5YN/A
EBIT growth 1Y0.7%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year11.8%
EBIT Next 3Y7.1%
EBIT Next 5YN/A
FCF growth 1Y-28.86%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y-4.37%
OCF growth 3Y12.5%
OCF growth 5Y4.86%